FDA Approved: EXEMESTANE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approval of a supplemental application for Exemestane by Mylan Pharmaceuticals Inc. is noted. Exemestane is a drug used in the treatment of breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Exemestane (Exemestane)

Snippet

SUPPL AP for EXEMESTANE (EXEMESTANE)